Mar 26 |
GTG Global Collaborations and Innovation Update
|
Mar 25 |
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
|
Mar 8 |
One Genetic Technologies Insider Raised Stake By 20% In Previous Year
|
Feb 28 |
GTG to launch U.S. Customer Digital Media Sales Campaign
|
Jan 31 |
Launching our most comprehensive test and expanding into new global markets
|
Jan 5 |
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
|
Dec 29 |
Genetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
|
Dec 14 |
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
|
Dec 12 |
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
|
Nov 15 |
Here's Why Shareholders May Want To Be Cautious With Increasing Genetic Technologies Limited's (ASX:GTG) CEO Pay Packet
|